文献速递泌尿系结石前列腺增生与排尿功能障碍

新型抗反流「RELIEF」支架预防膀胱输尿管反流

Novel Antireflux "RELIEF" Stent to Prevent Vesicoureteral Reflux.
PubMed 文献 · Urology · 2024-02-24

单中心纳入28例患者,评估新型RELIEF输尿管支架(以漂浮单丝系绳替代传统双J管远端半硬线圈)的疗效、舒适度与症状。20枚支架置入后95%无膀胱输尿管反流,无意外不良并发症,1例因明显不适提前拔管;USSQ总分及身体疼痛、总体健康、工作表现评分在首次与第三次调查间均有统计学显著改善。

要点

  • 20枚RELIEF支架置入后95%无膀胱输尿管反流,无意外不良并发症。
  • 1例患者因明显不适选择提前拔除支架。
  • USSQ总分及身体疼痛、总体健康、工作表现评分首次与第三次调查间显著改善。

核心结论

  • RELIEF支架可消除膀胱输尿管反流,支架相关并发症与总体耐受性与传统支架相似。
  • RELIEF相关USSQ评分低于已发表的传统双J管平均症状评分,在此初步临床试验中看似安全。

研究设计与样本

  • 单中心纳入28例患者,置入20枚RELIEF支架(女性11例、男性9例)。
  • 置入前后行被动膀胱造影评估膀胱输尿管反流。
  • 患者在置入前(基线)、术后第1天及拔管日完成输尿管支架症状问卷(USSQ)。

主要发现

  • 20枚RELIEF支架置入后95%无膀胱输尿管反流。
  • 无意外不良并发症发生;1例患者因明显不适选择提前拔除支架。
  • USSQ平均总分首次与第三次调查间有统计学显著改善(P < .001)。
  • 身体疼痛、总体健康与工作表现评分亦有统计学显著改善(P < .05)。

临床怎么用

  • 作者认为RELIEF支架可消除膀胱输尿管反流,支架相关并发症与总体耐受性相似,且在此初步临床试验中看似安全。
  • 作者指出RELIEF相关USSQ评分低于已发表的传统双J管平均症状评分。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess efficacy, comfort, and symptoms of a novel ureteral stent (RELIEF) substituting the distal semirigid coil of a traditional double-J for a floating, monofilament tether allowing coaptation of the ureteral orifice. Ureteral instrumentation notoriously cause discomfort, urgency, frequency, dysuria, and hematuria; prolonged morbidity is likely related to stent-associated vesicoureteral reflux (VUR). We hypothesized this design would eliminate VUR, be safe and provide comfort following intervention. METHODS: Twenty-eight patients within a single institution were enrolled. Passive cystography was performed pre- and post-stent placement assessing VUR. Patients completed Ureteric Stent Symptoms Questionnaires (USSQ) before placement (baseline), postop day 1, and day of removal. RESULTS: Twenty RELIEF stents were placed (11 female and 9 male). 95% demonstrated no VUR following placement. No unexpected adverse complications occurred; 1 patient opted for early stent removal for significant discomfort. Average total USSQ scores demonstrated statistically significant improvement between first and third surveys (P < .001). Statistically significant improvement in body pain, general health, and work performance scores were noted as well (P < .05). CONCLUSION: The RELIEF stent eliminates VUR with similar stent-related morbidity and overall well-tolerance. RELIEF-associated USSQ scores were below published mean symptom scores for standard double-J stents and appear safe in this preliminary clinical trial.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Callegari M, Patel A, Drozd A, et al. Novel Antireflux "RELIEF" Stent to Prevent Vesicoureteral Reflux. Urology. 2024. PMID: 38408491. doi:10.1016/j.urology.2024.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。